Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Oncology
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Oncology
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Novocure
MedTech
Novocure hit by cyberattack
Novocure is the latest medtech company hit by a cyberattack, with unauthorized access to some of its systems exposing patient and employee data.
Ben Adams
Sep 1, 2026 9:15am
Novocure device fails to improve brain cancer patients’ survival
Jun 18, 2026 8:25am
Novocure touts positive data in metastatic pancreatic cancer
Mar 27, 2026 10:32am
Novocure gets FDA nod for device targeting pancreatic cancer
Feb 17, 2026 4:15am
Novocure replaces CEO after less than a year
Dec 2, 2025 9:35am
Novocure's TTFields clear phase 3 pancreatic cancer trial
Dec 2, 2024 11:30am
